Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05845333 · ClinicalTrials.gov registry record
Neurocognitive Abnormalities in Stimulant Abuse Among High-Risk Women
A clinical trial of Criminal Behavior and Stimulant Abuse, sponsored by The Mind Research Network.
- Recruiting
- Registry status
- 334
- Enrollment target
- 1
- Study location
NCT05845333: Recruiting study of Criminal Behavior and Stimulant Abuse, sponsored by The Mind Research Network.
NCT05845333 is a study of Criminal Behavior and Stimulant Abuse that is actively recruiting participants, run by The Mind Research Network. The registered enrollment target is 334 participants, below the 7,820-participant average among 7 other Criminal Behavior trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05845333, a study of Criminal Behavior and Stimulant Abuse, is actively recruiting participants, sponsored by The Mind Research Network.
- RECRUITING
- Registry status
- 334 participants
- Enrollment target
- 1
- Study location
Study Summary
Substance use disorders and psychopathy are serious and costly mental health issues. Psychopathy is known to be associated with aberrant moral decision making and there is considerable interest in determining whether substance use disorders lead to impairments in these same cognitive processes. Recent large-scale research initiatives in forensic settings have begun to identify substance abuse and psychopathy-related disruption in the neural mechanisms involved in moral decision-making processes, and associations between these neural networks and future relapse and antisocial behavior. Here the investigators extend prior work (with incarcerated men) to examine these issues among incarcerated women in order to better understand sex differences. This project addresses the overall lack of neurocognitive research in criminal offenders with substance use disorders, thereby focusing on a major public health issue in an underserved and understudied population.
Primary Outcome
Gray matter volume (using relevant MRI analysis platforms - Statistical Parametric Mapping/SPM) correlation with stimulant use (assessed using a modified version of the Addiction Severity Index)
Conditions Studied
Interventions
- OTHER Decision task
Study Locations (1)
New Mexico
- The Mind Research Network - Albuquerque
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 334 participants |
| Start Date | 2022-08-01 |
| Est. Completion | 2027-05-31 |
What NCT05845333 shows while recruiting
NCT05845333 is an observational study that tracks outcomes without assigning an intervention. The registered 334 participants enrollment target is mid-sized for trials with a published cap, below the 7,820-participant average among 7 other Criminal Behavior trials with a reported enrollment target (96% lower).
The record links to 2 conditions, with Criminal Behavior appearing as the primary indexed condition, and to 1 intervention - of which Decision task is the first listed.
NCT05845333 reports a single indexed study location in New Mexico.
Frequently Asked Questions
What is clinical trial NCT05845333 about?
NCT05845333 is a clinical study titled "Neurocognitive Abnormalities in Stimulant Abuse Among High-Risk Women". Substance use disorders and psychopathy are serious and costly mental health issues. Psychopathy is known to be associated with aberrant moral decision making and there is considerable interest in determining whether substance use disorders lead to impairments in these same cognitive processes. Rece...
What is the current status of trial NCT05845333?
This trial is currently recruiting. The enrollment target is 334 participants. The study started on 2022-08-01. Estimated completion is 2027-05-31.
What conditions does trial NCT05845333 study?
This clinical trial studies the following conditions: Criminal Behavior, Stimulant Abuse.
What interventions are being tested in trial NCT05845333?
The interventions under investigation include: Decision task (OTHER).
Who is sponsoring clinical trial NCT05845333?
This trial is sponsored by The Mind Research Network, which has 17 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05845333 being conducted?
This trial has 1 study location across New Mexico. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Criminal Behavior
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Dialectical Behavior Therapy for Justice-Involved Veterans
RECRUITING · NA
-
Removing Barriers: Community Partnering for Innovative Solutions to the Opioid Crisis
RECRUITING · NA
-
The Community Youth Development Study: A Test of Communities That Care
ACTIVE NOT RECRUITING · NA
-
Catholic Health Initiatives (CHI) St. Joseph's Children Home Visiting Longitudinal Study
ACTIVE NOT RECRUITING · NA
-
Using Re-inforcement Learning to Automatically Adapt a Remote Therapy Intervention (RTI) for Reducing Adolescent Violence Involvement
ACTIVE NOT RECRUITING · NA
-
Mindfulness for Alcohol Abusing Offenders
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05131672 · 334 participants · NA
Cast or Operation for Medial Epicondyle Fracture Treatment in Children
- NCT05131685 · 334 participants · NA
Distal Radius Interventions for Fracture Treatment
- NCT05546931 · 334 participants · NA
Mobile Health Program for Rural Hypertension
- NCT05722197 · 334 participants · NA
Assessment of Emotion Regulation Strategies Used When Suicidal
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI